Q2 2022 Medigene AG Earnings Call Transcript
Good afternoon and good morning to the US. My name is Anna Niedl. I'm responsible for the investor relations at Medigene. I would like to welcome everyone to today's conference call in which we will describe Medigene's financial and operational results in the first half year of 2022.
Today's presentation, as always, is available for download on our website. And this call will be recorded and will be accessible later on our website as well in the same section. With me today here on this conference call are Professor Dolores Schendel, our Chief Scientific Officer; and Dr. Birger Kohlert, our Chief Financial Officer.
I would now like to draw your attention to slide 2 of the presentation and would like to remind you, as usual, that during this conference call, we will present and discuss certain forward-looking statements. And with this said, I hand over to Dolores Schendel and slide 3 of the presentation.
Thank you, Anna. So
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
